SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-012414
Filing Date
2017-01-18
Accepted
2017-01-18 16:57:02
Documents
10
Effectiveness Date
2017-01-18

Document Format Files

Seq Description Document Type Size
1 DEFA14A d309063ddefa14a.htm DEFA14A 66409
2 GRAPHIC g309063dps005.jpg GRAPHIC 362498
3 GRAPHIC g309063dsp004.jpg GRAPHIC 184789
4 GRAPHIC g309063dsp006.jpg GRAPHIC 474974
5 GRAPHIC g309063dsp007.jpg GRAPHIC 506687
6 GRAPHIC g309063dsp008.jpg GRAPHIC 471746
7 GRAPHIC g309063dsp009.jpg GRAPHIC 477136
8 GRAPHIC g309063dsp010.jpg GRAPHIC 326891
9 GRAPHIC g309063dsp011.jpg GRAPHIC 279020
10 GRAPHIC g309063dsp012.jpg GRAPHIC 175544
  Complete submission text file 0001193125-17-012414.txt   4557228
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35409 | Film No.: 17533968
SIC: 2834 Pharmaceutical Preparations